Find the latest clinical trials by condition, location & phase
Browse and search for drug information and related clinical trials
Explore a comprehensive list of organizations, including their profiles and details.
Latest updates on clinical trials, pharmaceuticals, and healthcare companies
Stay informed with timely notifications on clinical trials and research advancements.
No overview information available.
No background information available.
No indication information available.
No associated conditions information available.
Incannex Healthcare reported positive Phase 2 results for PSX-001 in treating generalized anxiety disorder (GAD), showing significant anxiety reduction with synthetic psilocybin and psychotherapy.
Incannex Healthcare has secured a financing agreement with Arena Investors for up to $60 million to advance its clinical-stage drug candidates.